Meta-analysis of neutropenia and infection rates. Forest plots depicting infection and neutropenia prevalence stratified by patients receiving BsAb therapy as monotherapy and those receiving in combination with chemoimmunotherapy. Panels A-B depict prevalence of all-grade infections, and panels C-D show neutropenia rates.